Prostate Summit is Presented by the Northwestern University Feinberg School of Medicine and Offers Physicians and Health Care Professionals Live Interactive Video and Real-Time Q&A with Renown Prostate Cancer Oncologists
BOSTON, April 9, 2012 (GLOBE NEWSWIRE) -- Northwestern University Feinberg School of Medicine and PlatformQ Health, the leader in live online events, today announced www.ProstateSummit.com, the first-ever online-only conference for urologists, internists, family physicians and other medical professionals to better diagnose and treat patients with prostate cancer. The free virtual program will be held Tuesday April 17th between 9:00 AM and 6:00 PM Eastern and offers a maximum of 6 AMA PRA Category 1 Credits™.
The day-long continuing medical educational program with individual video sessions beginning on the hour was designed by course directors Judd W. Moul, MD, FACS, of Duke University Medical Center and Anthony J. Schaeffer, MD, of the Northwestern University Feinberg School of Medicine. The CME program will bring together national experts Dr. William Catalona, Dr. Phillip Kantoff, Dr. Oliver Sartor and Dr. Leonard Gomella, MD to discuss the latest prostate cancer screening methods and will debate different treatment strategies. Prostate Summit is supported by educational grants from Abbott Laboratories, Bayer Healthcare Pharmaceuticals, Ferring Pharmaceuticals, Janssen Biotech and Teva Pharmaceuticals.
To register for this free event, health professionals can visit www.prostatesummit.com. Participants can choose from eight 1-hour interactive sessions:
9:00 AM
Prostate Cancer Screening: New Possibilities and Practical Risk Management
William J. Catalona, MD, Northwestern University Feinberg School of Medicine
Moderator: Anthony J. Schaeffer, MD, Northwestern University Feinberg School of Medicine
10:00 AM
Androgen Deprivation Therapy in Prostate Cancer: Controversies and Conflicts
E. David Crawford, MD, University of Colorado
Moderator: Anthony J. Schaeffer, MD, Northwestern University Feinberg School of Medicine
11:00 AM
Individualizing Therapy for the Prostate Cancer Patient: A Growing Set of Options
Judd W. Moul, MD, FACS, Duke University Medical Center
Moderator: Leonard G. Gomella, MD, FACS, Thomas Jefferson University
12:00 PM
Managing Bone Health and other Post-intervention Issues
Joel B. Nelson, MD, University of Pittsburgh School of Medicine
Moderator: Judd W. Moul, MD, FACS, Duke University Medical Center
1:00 PM
An Oral Therapy Shown to Improve Overall Survival in Metastatic Castration-Resistant Prostate Cancer (CRPC)
Dr. Michael Rettig, MD, Medical Director Prostate Cancer Program David Geffen School of Medicine at UCLA
2:00 PM
Novel Therapies for Advanced Prostate Cancer: What Does the Future Hold?
Philip W. Kantoff, MD, Harvard Medical School, Brigham And Women's Hospital
3:00 PM
Prostate Cancer: To Screen or Not to Screen
Stephen B. Williams, MD, Associated Urologists of Orange County
5:00 PM
The Hormone-Refractory Prostate Cancer Patient: What Now?
Oliver Sartor, MD, Tulane University School of Medicine
"According to the National Cancer Institute, 1 in 6 men will be diagnosed with cancer of the prostate during their lifetime, said Dr. Judd Moul, Co-Course Director for the Prostate Summit. "Given the prevalence of prostate cancer, this program is designed to better educate practitioners on new developments in prostate cancer research and treatment in a way that is both effective and convenient—from the ease of any computer." Physicians, physician assistants, nurse practitioners and other healthcare professionals who login and attend the complimentary program can have their questions addressed live via video by leading experts in prostate cancer care. The event offers live keynote presentations with Q & A, peer networking and a virtual exhibit floor online at Prostate Summit. Acknowledging the busy lives of physicians, all video presentations will be available on-demand in enduring format after the live event concludes.
Prostate Summit features leading oncologists from respected teaching hospitals such as William J. Catalona, MD, of Northwestern University Feinberg School of Medicine who is currently conducting research into the genetics of prostate cancer which could lead to new tests and treatments for the disease and is a recognized as an expert in performing the "nerve-sparing" radical prostatectomy that can preserve sexual potency and Oliver Sartor, MD, of Tulane University School of Medicine , chairman-elect of the Department of Defense Integration Panel for prostate cancer research as well as co-editor-in-chief of the peer-reviewed journal Clinical Genitourinary Cancer. To view the latest agenda or to register now for free, visit www.ProstateSummit.com.
ABOUT PROSTATE SUMMIT
www.ProstateSummit.com, is a free virtual medical conference which takes place entirely online, enabling healthcare practitioners and others interested in screening and treating patients with prostate cancer to learn, connect and interact online. Prostate Summit is presented by the Northwestern University Feinberg School of Medicine and is produced by PlatformQ Health, whose mission is to connect people, companies, organizations and associations worldwide to meet, interact and learn from leading experts and thought leaders through proven interactive tools at online events.
Prostate Summit and PlatformQ Health are trademarks of PlatformQ, LLC. All other trademarks or service marks are property of their respective owners.
ACCREDITATION STATEMENT
Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENTS
The Northwestern University Feinberg School of Medicine designates this educational activity for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
CONTINUING EDUCATION – NURSES
Northwestern Memorial Hospital-NM Academy is an approved provider of continuing nursing education by the Illinois Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation
OTHER CREDITS
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 6 hours of Category 1 credit for completing these programs.
DATE OF RELEASE
Live sessions will be available April 17, 2011 from 9:00 AM-6:00 PM (Eastern).
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
- Evaluate new options for prostate cancer risk testing and effectively manage practical issues associated with elevated PSA and follow-up testing.
- Initiate patient-centered discussions on individualizing prostate cancer treatments based on the patient's age, medical history, and current health status, among others.
- Review currently available therapies for hormone-resistant or refractory prostate cancer (HRPC), identifying through a case-based method which approach is most appropriate for a specific patient.
- Discuss novel therapies available for the treatment of advanced and hormone-resistant prostate cancer, including mechanism of action, efficacy, and adverse effects.
- Properly apply the use of androgen deprivation therapy (ADT) along the spectrum of prostate cancer.
- Successfully manage bone health and other post-intervention complications, including incontinence, in patients with prostate cancer.
TARGET AUDIENCE
Healthcare professionals who detect, diagnose, manage and treat prostate cancer and related urologic conditions. Medical oncologists, radiation oncologists, urologists, and oncology nurses, involved in caring for patients with prostate cancer are the primary audience for this event. Secondary audiences include primary care physicians, family physicians, nurses and advanced practice nurses, physician assistants, and pharmacists.
FACULTY DISCLOSURE
Current guidelines state that participants in CME and CE activities should be made aware of any affiliation or financial interest that may affect a speaker's presentation. Speakers are required to disclose any significant relationships with commercial companies prior to the symposium. The course syllabus will identify any significant relationships and whether a faculty member will be discussing off-label usage.
This information was brought to you by Cision http://www.cisionwire.com
http://www.cisionwire.com/cardiocarelive--the-online-cardiology-congress/r/world-renowned-experts-gather-on-tuesday-april-17-for-first-ever-online-prostate-summit-to-discuss-p,c9244135
The following files are available for download:
| wkr0006.pdf | www.ProstateSummit.com Live Online CME April 17 |